Mesa Laboratories (MLAB) Misses Q4 EPS by 229c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts MLAB Hot Sheet
Price: $125.48 +2.88%
Financial Fact:
Average Common Shares Outstanding (Diluted) (in shares): 3.83M
Today's EPS Names:
FACO, SEB, SGHC, More
Financial Fact:
Average Common Shares Outstanding (Diluted) (in shares): 3.83M
Today's EPS Names:
FACO, SEB, SGHC, More
Join SI Premium – FREE
Mesa Laboratories (NASDAQ: MLAB) reported Q4 EPS of ($0.75), $2.29 worse than the analyst estimate of $1.54. Revenue for the quarter came in at $63.72 million versus the consensus estimate of $65.2 million.
For earnings history and earnings-related data on Mesa Laboratories (MLAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- trivago (TRVG) Misses Q3 EPS by 3c
- Tarsus Pharmaceuticals, Inc. (TARS) Misses Q3 EPS by 1293c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
